Quantcast
Last updated on April 18, 2014 at 13:47 EDT

Latest Ronald A. Depinho Stories

2014-01-09 11:35:24

Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer...

2012-10-31 15:25:15

NATICK, Mass., Oct. 31, 2012 /PRNewswire/ -- Ronald A. DePinho, M.D., a co-founder and board member of Karyopharm Therapeutics Inc. since 2009, elected to resign from the company's board of directors, effective Oct. 10, 2012, at a time when the company has achieved a "strong base of operations." "I am proud of the stellar group of physicians and scientists at Karyopharm who are focused on the needs of cancer patients," Dr. DePinho said. "With the transition of its nuclear transport...

Center Calling Shot To Put An End To Cancer
2012-09-21 18:57:48

Lee Rannals for redOrbit.com — Your Universe Online Fifty years after President John F. Kennedy made the call to put an American on the moon before the end of the decade, Houston's MD Anderson Cancer Center is making the call to significantly reduce the number of deaths from cancers by the end of the decade. The center is launching its "Moon Shots Program" as a way to rally up researchers, and put an end to cancer. "Inspired by America´s drive generations ago to put a man...

2012-05-08 02:28:00

NATICK, Mass., May 8, 2012 /PRNewswire/ -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, announces that co-founder Ronald A. DePinho MD, President of MD Anderson Cancer Center, has been appointed to the National Academy of Sciences. (Logo: http://photos.prnewswire.com/prnh/20120508/NE02031LOGO ) Dr. DePinho has been a pioneer in cancer research for over 20 years. His laboratory has produced an array of discoveries including improved mouse models...

2010-11-30 16:32:00

RENO, Nev., Nov. 30, 2010 /PRNewswire/ -- On Sunday, a team of scientists at Harvard Medical School led by Dr. Ronald DePinho published research providing strong scientific support for the validity of Sierra Sciences' approach to curing aging. Their research demonstrated for the first time that turning on telomerase and lengthening telomeres will reverse the symptoms of old age in a living animal. These findings appear as a research article entitled 'Telomerase reactivation reverses...

94834c02f4195bdc90f120cb6da5fba01
2010-11-29 12:55:00

Harvard scientists believe they might be a step closer to reversing the aging process. The researchers at Harvard Medical School developed an experimental treatment that turned weak and feeble old mice into healthy animals by regenerating their aged bodies. The surprise recovery of the mice raised hopes among scientist that it may be possible to achieve a similar accomplishment in humans. An anti-aging therapy could have a dramatic impact on public health by reducing the burden of...

2010-03-16 10:20:00

BETHESDA, Md., March 16 /PRNewswire/ -- The National Foundation for Cancer Research announced today that renowned scientist Peter K. Vogt, Ph.D., Professor in the Department of Molecular and Experimental Medicine at The Scripps Research Institute, La Jolla, California, is the recipient of the 5th Annual Szent-Gyorgyi Prize for Progress in Cancer Research. Dr. Vogt's research, which began on a humble chicken virus in the early 1960s, has profoundly changed biology and medicine. His...

38508ae616ec8fa46825b55622d1dac71
2005-08-05 08:15:00

'Cellular senescence' might be used to put tumors to sleep, research suggests A new strategy for fighting -- and perhaps preventing -- cancer has emerged from research on the genetics of malignant cells. The concept: Don't kill those cells, as is now done, but put them into a biological form of suspended animation called cellular senescence. Four research groups, in the United States and abroad, are reporting studies in the Aug. 4 issue of Nature showing that this approach is a realistic new...